アスパラギン酸 |
|
|
IUPAC名
Trivial: Aspartic acid
Systematic: 2-Aminobutanedioic acid
|
別称
Aminosuccinic acid, asparagic acid, asparaginic acid[1]
|
識別情報 |
CAS登録番号 |
617-45-8 ,
56-84-8 (L-体)
1783-96-6 (D-体) |
PubChem |
424 |
ChemSpider |
411 |
UNII |
28XF4669EP |
EINECS番号 |
200-291-6 |
KEGG |
C00049 |
ChEMBL |
CHEMBL139661 |
- O=C(O)CC(N)C(=O)O
C(C(C(=O)O)N)C(=O)O
|
- InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)
Key: CKLJMWTZIZZHCS-UHFFFAOYSA-N
InChI=1/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)
Key: CKLJMWTZIZZHCS-UHFFFAOYAE
|
特性 |
化学式 |
C4H7NO4 |
モル質量 |
133.1 g mol−1 |
特記なき場合、データは常温 (25 °C)・常圧 (100 kPa) におけるものである。 |
アスパラギン酸(アスパラギンさん、aspartic acid)とは、アミノ酸のひとつで、2-アミノブタン二酸のこと。示性式は HOOCCH2CH(COOH)NH2)。略号はD あるいは Asp。光学異性体としてL体とD体の両方が存在する。アスパラギンの加水分解物から単離され、由来とその構造からこの名がついた。
酸性極性側鎖アミノ酸に分類される。L体のアスパラギン酸は蛋白質を構成するアミノ酸のひとつ。非必須アミノ酸で、グリコーゲン生産性を持つ。うま味成分のひとつ。
致死量はLD50=16g/kgである。
目次
- 1 生合成
- 2 工業生産
- 3 物性
- 4 神経伝達物質
- 5 関連項目
- 6 出典
- 7 外部リンク
生合成
生体内では、クエン酸回路の一員であるオキサロ酢酸が、アスパラギン酸アミノトランスフェラーゼ (EC 2.6.1.1) によるグルタミン酸からのアミノ基の転移を受けて生合成される。
oxaloacetate + L-glutamate → L-aspartate + 2-oxoglutarate
工業生産
工業的にはフマル酸とアンモニアを原料として大腸菌由来のアスパルターゼを用いる。大腸菌はκ-カラギーナンで固定化され、バイオリアクターを用いて回分法で生産される。
物性
- 分子量 133.10
- 等電点 2.77
- 溶解性 水にやや難溶、エタノール・ジエチルエーテルに不溶。希塩酸・希硫酸に可溶。
- 溶解度(水、g/100g)0.42 (20℃)、0.85 (40℃)、1.70 (60℃)
- ファンデルワールス半径 91
神経伝達物質
アスパラギン酸は中枢神経系の興奮性神経伝達物質で、大脳皮質、小脳及び脊髄などに存在する[2]NMDA受容体に対しアゴニストとして作用する。アミノ酸系の神経伝達物質は、アスパラギン酸に加えてグルタミン酸(Glu)、γ-アミノ酪酸(GABA)、グリシン(Gly)がある[3]。
関連項目
リンゴ酸-アスパラギン酸シャトル
出典
- ^ “862. Aspartic acid”. The Merck Index (11th ed.). (1989). p. 132. ISBN 091191028X.
- ^ 神経伝達: 神経疾患: メルクマニュアル18版 日本語版
- ^ 痛みと鎮痛の基礎知識 - Pain Relief ー伝達物質
外部リンク
- アスパラギン酸 - 「健康食品」の安全性・有効性情報 (国立健康・栄養研究所)
タンパク質を構成するアミノ酸 |
|
主なトピック |
|
|
|
特性 |
脂肪族
|
- 分枝鎖アミノ酸 (バリン
- イソロイシン
- ロイシン)
- メチオニン
- アラニン
- プロリン
- グリシン
|
|
芳香族
|
- フェニルアラニン
- チロシン
- トリプトファン
- ヒスチジン
|
|
極性なし
|
|
|
正電荷 (pKa)
|
- リシン (≈10.8)
- アルギニン (≈12.5)
- ヒスチジン (≈6.1)
|
|
負電荷 (pKa)
|
- アスパラギン酸 (≈3.9)
- グルタミン酸 (≈4.1)
- システイン (≈8.3)
- チロシン (≈10.1)
|
|
|
分類 |
- 必須アミノ酸
- ケト原性アミノ酸
- 糖原性アミノ酸
- タンパク質を構成しないアミノ酸(英語版)
|
|
- 主要な生体物質
- 炭水化物
- アルコール
- 糖タンパク質
- 配糖体
- 脂質
- エイコサノイド
- 脂肪酸/脂肪酸の代謝中間体
- リン脂質
- スフィンゴ脂質
- ステロイド
- 核酸
- 核酸塩基
- ヌクレオチド代謝中間体
- タンパク質
- タンパク質を構成するアミノ酸/アミノ酸の代謝中間体
- テトラピロール
- ヘムの代謝中間体
|
|
Aspartic acid
|
|
Names |
IUPAC names
Trivial: Aspartic acid
Systematic: 2-Aminobutanedioic acid
|
Other names
Aminosuccinic acid, asparagic acid, asparaginic acid[1]
|
Identifiers |
CAS Number
|
617-45-8 Y
56-84-8 (L-isomer) N
1783-96-6 (D-isomer) N |
ChEBI |
CHEBI:22660 Y |
ChEMBL |
ChEMBL139661 Y |
ChemSpider |
411 Y |
EC Number |
200-291-6 |
Jmol 3D model |
Interactive image
Interactive image |
KEGG |
C16433 Y |
PubChem |
424 |
UNII |
28XF4669EP Y |
InChI
-
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9) Y
Key: CKLJMWTZIZZHCS-UHFFFAOYSA-N Y
-
InChI=1/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)
Key: CKLJMWTZIZZHCS-UHFFFAOYAE
|
SMILES
-
O=C(O)CC(N)C(=O)O
-
C(C(C(=O)O)N)C(=O)O
|
Properties |
Chemical formula
|
C4H7NO4 |
Molar mass |
133.10 g·mol−1 |
Appearance |
colourless crystals |
Density |
1.7 g/cm3 |
Melting point |
270 °C (518 °F; 543 K) |
Boiling point |
324 °C (615 °F; 597 K) (decomposes) |
Solubility in water
|
4.5 g/L[2] |
Acidity (pKa) |
3.9 |
Hazards |
Safety data sheet |
See: data page |
NFPA 704 |
|
Supplementary data page |
Structure and
properties
|
Refractive index (n),
Dielectric constant (εr), etc. |
Thermodynamic
data
|
Phase behaviour
solid–liquid–gas |
Spectral data
|
UV, IR, NMR, MS |
N verify (what is YN ?) |
Infobox references |
|
|
Aspartic acid (abbreviated as Asp or D; encoded by the codons [GAU and GAC]), also known as aspartate, is an α-amino acid that is used in the biosynthesis of proteins. It contains an α-amino group (which is in the protonated −NH+
3 form under biological conditions), an α-carboxylic acid group (which is in the deprotonated −COO− form under biological conditions), and a side chain CH2COOH. Under physiological conditions in proteins the sidechain usually occurs as the negatively charged aspartate form, −COO−. It is semi-essential in humans, meaning the body can synthesize it from oxaloacetate.
In proteins aspartate sidechains are often hydrogen bonded, often as asx turns or asx motifs, which often occur at the N-termini of alpha helices.
Asp's L-isomer is one of the 23 proteinogenic amino acids, i.e., the building blocks of proteins. Asp (and glutamic acid) is classified as acidic, with a pKa of 3.9, however in a peptide this is highly dependent on the local environment (as with all amino acids), and could be as high as 14. Asp is pervasive in biosynthesis.
L-aspartic acid is one of the two main ingredients of the artificial sweetener aspartame, along with L-phenylalanine.
Contents
- 1 Discovery
- 2 Forms and nomenclature
- 3 Metabolism
- 4 Other biochemical roles
- 4.1 Interactive pathway map
- 4.2 Neurotransmitter
- 5 Sources
- 5.1 Dietary sources
- 5.2 Chemical synthesis
- 6 See also
- 7 References
- 8 External links
Discovery
Aspartic acid was first discovered in 1827 by Auguste-Arthur Plisson and Étienne Ossian Henry,[3] derived from asparagine, which had been isolated from asparagus juice in 1806, by boiling with a base.[4]
Forms and nomenclature
There are two forms or enantiomers of aspartic acid. The name "aspartic acid" can refer to either enantiomer or a mixture of two.[5] Of these two forms, only one, "L-aspartic acid", is directly incorporated into proteins. The biological roles of its counterpart, "D-aspartic acid" are more limited. Where enzymatic synthesis will produce one or the other, most chemical syntheses will produce both forms, "DL-aspartic acid," known as a racemic mixture.
Metabolism
Aspartate is non-essential in mammals, being produced from oxaloacetate by transamination. It can also be generated from ornithine and citrulline in the urea cycle. In plants and microorganisms, aspartate is the precursor to several amino acids, including four that are essential for humans: methionine, threonine, isoleucine, and lysine. The conversion of aspartate to these other amino acids begins with reduction of aspartate to its "semialdehyde," O2CCH(NH2)CH2CHO.[6] Asparagine is derived from aspartate via transamidation:
- -O2CCH(NH2)CH2CO2- + GC(O)NH3+ O2CCH(NH2)CH2CONH3+ + GC(O)O
(where GC(O)NH2 and GC(O)OH are glutamine and glutamic acid, respectively)
Other biochemical roles
Aspartate is also a metabolite in the urea cycle and participates in gluconeogenesis. It carries reducing equivalents in the malate-aspartate shuttle, which utilizes the ready interconversion of aspartate and oxaloacetate, which is the oxidized (dehydrogenated) derivative of malic acid. Aspartate donates one nitrogen atom in the biosynthesis of inosine, the precursor to the purine bases. In addition, aspartic acid acts as hydrogen acceptor in a chain of ATP synthase.
Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles. [§ 1]
[[File:
|{{{bSize}}}px|alt=Glycolysis and Gluconeogenesis edit]]
File:WP534.png
Glycolysis and Gluconeogenesis edit
- ^ The interactive pathway map can be edited at WikiPathways: "GlycolysisGluconeogenesis_WP534".
Neurotransmitter
Aspartate (the conjugate base of aspartic acid) stimulates NMDA receptors, though not as strongly as the amino acid neurotransmitter L-glutamate does.[7]
Sources
Dietary sources
Aspartic acid is not an essential amino acid, which means that it can be synthesized from central metabolic pathway intermediates in humans. Aspartic acid is found in:
- Animal sources: oysters, luncheon meats, sausage meat, wild game
- Vegetable sources: sprouting seeds, oat flakes, avocado,[8] asparagus,[9] young sugarcane, and molasses from sugar beets.[1]
- Dietary supplements, either as aspartic acid itself or salts (such as magnesium aspartate)
- The sweetener aspartame (brands: NutraSweet, Equal, Canderel, etc.)
Chemical synthesis
Racemic aspartic acid can be synthesized from diethyl sodium phthalimidomalonate, (C6H4(CO)2NC(CO2Et)2).[10]
The major disadvantage of the above technique is that equimolar amounts of each enantiomer are made. Using biotechnology it is now possible to use immobilised enzymes to create just one type of enantiomer owing to their stereospecificity.
See also
- Aspartate transaminase
- Polyaspartic acid
- Sodium poly(aspartate), a synthetic polyamide
References
- ^ a b "862. Aspartic acid". The Merck Index (11th ed.). 1989. p. 132. ISBN 0-911910-28-X.
- ^ "ICSC 1439 - L-ASPARTIC ACID". inchem.org.
- ^ Berzelius, Jöns Jakob; Öngren, Olof Gustaf (1839). Traité de chimie (in French) 3. Brussels: A. Wahlen et Cie. p. 81. Retrieved 25 August 2015.
- ^ R.H.A. Plimmer (1912) [1908]. R.H.A. Plimmer & F.G. Hopkins, ed. The chemical composition of the proteins. Monographs on biochemistry. Part I. Analysis (2nd ed.). London: Longmans, Green and Co. p. 112. Retrieved January 18, 2010.
- ^ "Nomenclature and symbolism for amino acids and peptides (IUPAC-IUB Recommendations 1983)", Pure Appl. Chem. 56 (5): 595–624, 1984, doi:10.1351/pac198456050595 .
- ^ Lehninger, Albert L.; Nelson, David L.; Cox, Michael M. (2000), Principles of Biochemistry (3rd ed.), New York: W. H. Freeman, ISBN 1-57259-153-6 .
- ^ Chen, Philip E.; Geballe, Matthew T.; Stansfeld, Phillip J.; Johnston, Alexander R.; Yuan, Hongjie; Jacob, Amanda L.; Snyder, James P.; Traynelis, Stephen F.; Wyllie, David J. A. (2005). "Structural Features of the Glutamate Binding Site in Recombinant NR1/NR2A N-Methyl-D-aspartate Receptors Determined by Site-Directed Mutagenesis and Molecular Modeling". Mol. Pharmacol. 67 (5): 1470–84. doi:10.1124/mol.104.008185. PMID 15703381.
- ^ D. K. Salunkhe; S.S. Kadam (18 August 1995). Handbook of Fruit Science and Technology: Production, Composition, Storage, and Processing. CRC Press. pp. 368–. ISBN 978-0-8247-9643-3.
- ^ Douglas M. Considine (6 December 2012). Foods and Food Production Encyclopedia. Springer Science & Business Media. pp. 114–. ISBN 978-1-4684-8511-0.
- ^ Dunn, M. S.; Smart, B. W. (1950). "DL-Aspartic Acid". Org. Synth. 30: 7. ; Coll. Vol. 4, p. 55 .
External links
- GMD MS Spectrum
- American Chemical Society (21 April 2010). "Ancestral Eve' Crystal May Explain Origin of Life's Left-Handedness". ScienceDaily. Archived from the original on 23 April 2010. Retrieved 2010-04-21.
Other hematological agents
|
|
Antianemic
preparations
(B03) |
Erythropoietins |
- Darbepoetin alfa
- Methoxy polyethylene glycol-epoetin beta
- Peginesatide
|
|
Iron supplements |
- Ferrous ascorbate
- Ferrous aspartate
- Ferrous carbonate
- Ferrous chloride
- Ferrous fumarate
- Ferrous gluconate
- Ferrous glycine sulfate
- Ferrous iodine
- Ferrous succinate
- Ferrous sulfate
- Ferrous tartrate
- Iron sucrose
- Sodium ferric gluconate complex
|
|
|
Blood substitutes and
perfusion solutions (B05) |
- Dextran
- Gelatin agents
- Hemoglobin crosfumaril
- Hemoglobin raffimer
- Hydroxyethyl starch
- Icodextrin
- Mannitol
- Serum albumin
- Sorbitol
|
|
Enzymes (B06AA) |
- Bromelain
- Chymotrypsin
- Deoxyribonuclease
- Fibrinolysin
- Hyaluronidase
- Streptokinase
- Trypsin
|
|
Drugs used i hereditary
angioedema (B06AC) |
- C1-inhibitor
- Conestat alfa
- Ecallantide
- Icatibant
|
|
The encoded amino acid
|
|
General topics |
- Protein
- Peptide
- Genetic code
|
|
|
By properties |
Aliphatic
|
- Branched-chain amino acids (Valine
- Isoleucine
- Leucine)
- Methionine
- Alanine
- Proline
- Glycine
|
|
Aromatic
|
- Phenylalanine
- Tyrosine
- Tryptophan
- Histidine
|
|
Polar, uncharged
|
- Asparagine
- Glutamine
- Serine
- Threonine
|
|
Positive charge (pKa)
|
- Lysine (≈10.8)
- Arginine (≈12.5)
- Histidine (≈6.1)
|
|
Negative charge (pKa)
|
- Aspartic acid (≈3.9)
- Glutamic acid (≈4.1)
- Cysteine (≈8.3)
- Tyrosine (≈10.1)
|
|
|
Other classifications |
- Essential amino acid
- Ketogenic amino acid
- Glucogenic amino acid
- Non-proteinogenic amino acid
|
|
Neurotransmitters
|
|
Amino acid-derived |
- Major excitatory/inhibitory systems: Glutamate system: Agmatine
- Aspartic acid (aspartate)
- Cycloserine
- Glutamic acid (glutamate)
- Glutathione
- Glycine
- GSNO
- GSSG
- Kynurenic acid
- NAA
- NAAG
- Proline
- Serine; GABA system: GABA
- GABOB
- GHB; Glycine system: α-Alanine
- β-Alanine
- Glycine
- Hypotaurine
- Proline
- Sarcosine
- Serine
- Taurine; GHB system: GHB
- T-HCA (GHC)
- Biogenic amines: Monoamines: 6-OHM
- Dopamine
- Epinephrine (adrenaline)
- Melatonin
- NAS (normelatonin)
- Norepinephrine (noradrenaline)
- Serotonin (5-HT); Trace amines:
- 3-Iodothyronamine
- N-Methylphenethylamine
- N-Methyltryptamine
- m-Octopamine
- p-Octopamine
- Phenylethanolamine
- Phenethylamine
- Synephrine
- Tryptamine
- m-Tyramine
- p-Tyramine; Others: Histamine
- Neuropeptides: See here instead.
|
|
Lipid-derived |
- Endocannabinoids: 2-AG
- 2-AGE (noladin ether)
- 2-ALPI
- 2-OG
- AA-5-HT
- Anandamide (AEA)
- DEA
- LPI
- NADA
- NAGly
- OEA
- Oleamide
- PEA
- RVD-Hpα
- SEA
- Virodhamine (O-AEA)
- Neurosteroids: See here instead.
|
|
Nucleobase-derived |
- Nucleosides: Adenosine system: Adenosine
- ADP
- AMP
- ATP
|
|
Vitamin-derived |
- Cholinergic system: Acetylcholine
|
|
Miscellaneous |
- Gasotransmitters: Carbon monoxide (CO)
- Hydrogen sulfide (H2S)
- Nitric oxide (NO); Candidates: Acetaldehyde
- Ammonia (NH3)
- Carbonyl sulfide (COS)
- Nitrous oxide (N2O)
- Sulfur dioxide (SO2)
|
|
Glutamatergics
|
|
Receptor
(ligands) |
AMPA |
- Agonists: Glutamate/active site agonists: 5-Fluorowillardiine
- Acromelic acid (acromelate)
- AMPA
- BOAA
- Domoic acid
- Glutamate
- Ibotenic acid
- Proline
- Quisqualic acid
- Willardiine; Positive allosteric modulators: Aniracetam
- Cyclothiazide
- CX-516
- CX-546
- CX-614
- Farampator (CX-691, Org 24448)
- CX-717
- CX-1739
- CX-1942
- Diazoxide
- Hydrochlorothiazide (HCTZ)
- IDRA-21
- LY-392,098
- LY-404,187
- LY-451,646
- LY-503,430
- Mibampator (LY-451,395)
- Org 26576
- Oxiracetam
- PEPA
- PF-04958242
- Piracetam
- Pramiracetam
- S-18986
- Sunifiram
- Unifiram
- Antagonists: ACEA-1011
- ATPO
- Becampanel
- Caroverine
- CNQX
- Dasolampanel
- DNQX
- Fanapanel (MPQX)
- GAMS
- GYKI-52466
- Kynurenic acid
- Kynurenine
- Licostinel (ACEA-1021)
- NBQX
- PNQX
- Selurampanel
- Tezampanel
- Theanine
- Topiramate
- YM90K
- Zonampanel; Negative allosteric modulators: Barbiturates (e.g., pentobarbital, sodium thiopental)
- Cyclopropane
- Enflurane
- Ethanol
- Evans blue
- GYKI-53,655
- Halothane
- Irampanel
- Isoflurane
- Perampanel
- Pregnenolone sulfate
- Talampanel
|
|
NMDA |
- Agonists: Glutamate/active site agonists: AMAA
- Aspartate
- Glutamate
- Homocysteic acid (L-HCA)
- Homoquinolinic acid
- Ibotenic acid
- NMDA
- Proline
- Quinolinic acid
- Tetrazolylglycine
- Theanine; Glycine site agonists: β-Fluoro-D-alanine
- ACBD
- ACC (ACPC)
- ACPD
- AK-51
- B6B21
- CCG
- D-Alanine
- D-Cycloserine
- D-Serine
- DHPG
- Dimethylglycine
- Glycine
- HA-966
- L-687,414
- L-Alanine
- L-Serine
- Milacemide
- Neboglamine (nebostinel)
- NRX-1074
- Rapastinel (GLYX-13)
- Sarcosine; Polyamine site agonists: Spermidine
- Spermine; Other positive allosteric modulators: 24S-Hydroxycholesterol
- DHEA
- DHEA sulfate
- Pregnenolone sulfate
- SAGE-718
- Antagonists: Competitive antagonists: AP5 (APV)
- AP7
- CGP-37849
- CGP-39551
- CGP-39653
- CGP-40116
- CGS-19755
- CPP
- LY-233,053
- LY-235,959
- LY-274,614
- MDL-100,453
- Midafotel (d-CPPene)
- NPC-12,626
- NPC-17,742
- PBPD
- PEAQX
- Perzinfotel
- PPDA
- SDZ-220581
- Selfotel; Noncompetitive antagonists: ARR-15,896
- Caroverine
- Dexanabinol
- FPL-12495
- FR-115,427
- Hodgkinsine
- Magnesium
- MDL-27,266
- NPS-1506
- Psychotridine
- Zinc; Uncompetitive pore blockers: 2-MDP
- 3-HO-PCP
- 3-MeO-PCE
- 3-MeO-PCMo
- 3-MeO-PCP
- 4-MeO-PCP
- 8A-PDHQ
- 18-MC
- α-Endopsychosin
- Alaproclate
- Amantadine
- Aptiganel
- Arketamine
- ARL-12,495
- ARL-15,896-AR
- ARL-16,247
- Budipine
- Conaridine
- Delucemine
- Dexoxadrol
- Dextrallorphan
- Dieticyclidine
- Diphenidine
- Dizocilpine
- Ephenidine
- Esketamine
- Etoxadrol
- Eticyclidine
- Fluorolintane
- Gacyclidine
- Ibogaine
- Ibogamine
- Indantadol
- Ketamine
- Ketobemidone
- Lanicemine
- Loperamide
- Memantine
- Methadone (Levomethadone)
- Methorphan (Dextromethorphan
- Levomethorphan)
- Methoxetamine
- Methoxphenidine
- Milnacipran
- Morphanol (Dextrorphan
- Levorphanol)
- NEFA
- Neramexane
- Nitromemantine
- Nitrous oxide
- Noribogaine
- Norketamine
- Orphenadrine
- PCPr
- Pethidine (meperidine)
- Phencyclamine
- Phencyclidine
- Propoxyphene
- Remacemide
- Rhynchophylline
- Rimantadine
- Rolicyclidine
- Sabeluzole
- Tabernanthine
- Tenocyclidine
- Tiletamine
- Tramadol
- Xenon; Glycine site antagonists: 4-Cl-KYN (AV-101)
- 5,7-DCKA
- 7-CKA
- ACC
- ACEA-1011
- ACEA-1328
- AV-101
- Carisoprodol
- CGP-39653
- CNQX
- DNQX
- Felbamate
- Gavestinel
- GV-196,771
- Kynurenic acid
- Kynurenine
- L-689,560
- L-701,324
- Licostinel (ACEA-1021)
- LU-73,068
- MDL-105,519
- Meprobamate
- MRZ 2/576
- PNQX
- ZD-9379; NR2B subunit antagonists: Besonprodil
- CERC-301 (MK-0657)
- CO-101,244 (PD-174,494)
- Eliprodil
- Haloperidol
- Ifenprodil
- Isoxsuprine
- Nylidrin
- Ro8-4304
- Ro25-6981
- Traxoprodil; Polyamine site antagonists: Arcaine
- Co 101676
- Diaminopropane
- Diethylenetriamine
- Huperzine A
- Putrescine
- Ro 25-6981; Unclassified/unsorted antagonists: Bumetanide
- Chloroform
- Cyclopropane
- D-αAA
- Diethyl ether
- Enflurane
- Ethanol
- Flufenamic acid
- Flupirtine
- Furosemide
- Halothane
- Isoflurane
- Metaphit
- Methoxyflurane
- Niflumic acid
- Pentamidine isethionate
- Piretanide
- Toluene
- Transcrocetin (saffron)
- Trichloroethane
- Trichloroethanol
- Trichloroethylene
- Xylene
|
|
Kainate |
- Agonists: Glutamate/active site agonists: 5-Bromowillardiine
- 5-Iodowillardiine
- Acromelic acid (acromelate)
- AMPA
- ATPA
- Domoic acid
- Glutamate
- Ibotenic acid
- Kainic acid
- LY-339,434
- Proline
- Quisqualic acid
- SYM-2081; Positive allosteric modulators: Cyclothiazide
- Diazoxide
- Enflurane
- Halothane
- Isoflurane
- Antagonists: ACEA-1011
- CNQX
- Dasolampanel
- DNQX
- GAMS
- Kynurenic acid
- Licostinel (ACEA-1021)
- LY-382,884
- NBQX
- NS102
- Selurampanel
- Tezampanel
- Theanine
- Topiramate
- UBP-302; Negative allosteric modulators: Barbiturates (e.g., pentobarbital, sodium thiopental)
- Enflurane
- Ethanol
- Evans blue
- NS-3763
- Pregnenolone sulfate
|
|
mGlu1 |
- Agonists: ACPD
- DHPG
- Glutamate
- Ibotenic acid
- Quisqualic acid
- Ro01-6128
- Ro67-4853
- Ro67-7476
- VU-71
- Antagonists: BAY 36-7620
- CPCCOEt
- Cyclothiazide
- LY-367,385
- LY-456,236
- MCPG
- NPS-2390
|
|
mGlu2 |
- Agonists: BINA
- CBiPES
- DCG-IV
- Eglumegad
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-404,039 (pomaglumetad)
- LY-487,379
- LY-566,332
- MGS-0028
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad; Positive allosteric modulators: JNJ-40411813 (ADX-71149)
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039
- PCCG-4; Negative allosteric modulators: Decoglurant
- RO4491533
|
|
mGlu3 |
- Agonists: CBiPES
- DCG-IV
- Eglumegad
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-404,039 (pomaglumetad)
- LY-487,379
- MGS-0028
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039; Negative allosteric modulators: Decoglurant
- RO4491533
|
|
mGlu4 |
- Agonists: Glutamate
- L-AP4
- PHCCC
- VU-001,171
- VU-0155,041; Positive allosteric modulators: MPEP
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|
mGlu5 |
- Agonists: ACPD
- ADX-47273
- CDPPB
- CHPG
- DFB
- DHPG
- Glutamate
- Ibotenic acid
- Quisqualic acid
- VU-1545
- Antagonists: CTEP
- DMeOB
- LY-344,545
- Mavoglurant
- MCPG
- NPS-2390
- Remeglurant
- SIB-1757
- SIB-1893; Negative allosteric modulators: Basimglurant
- Dipraglurant
- Fenobam
- GRN-529
- MPEP
- MTEP
- Raseglurant
|
|
mGlu6 |
- Agonists: Glutamate
- L-AP4
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|
mGlu7 |
- Agonists: AMN082
- Glutamate
- L-AP4
- Antagonists: CPPG
- MAP4
- MMPIP
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|
mGlu8 |
- Agonists: DCPG
- Glutamate
- L-AP4
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|
|
Transporter
(blockers) |
EAATs |
- Amphetamine
- Aspartic acid (aspartate)
- cis-ACBD
- DHKA
- Glutamic acid (glutamate)
- HIP-A
- HIP-B
- Kainic acid
- L-(-)-threo-3-Hydroxyaspartic acid
- L-αAA
- L-CCG-III ((2S,3S,4R)-CCG)
- L-Serine-O-sulphate (SOS)
- L-trans-2,4-PDC
- MPDC
- SYM-2081
- TBOA
- TFB-TBOA
- Theanine
- threo-3-Methylglutamic acid
- UCPH-101
- WAY-213,613
|
|
vGluTs |
- 4-Methylene-L-glutamate
- 6-(4'-Phenylstyryl)-QDC
- 6-Biphenyl-4-yl-QDC
- 7-CKA
- Acid red 114
- Amido black 10B (naphthol blue black)
- Bafilomycin A1
- Benzopurpurin 4B
- Bumetamide
- Chicago sky blue 6B
- Aspartic acid (aspartate)
- DIDS
- Direct blue 71
- Erythro-4-methyl-L-glutamic acid
- Evans blue
- Furosemide
- Glutamic acid (glutamate)
- Kynurenic acid
- Nigericin
- NPPB (N144)
- Ponceau SS
- Reactive blue 2
- Rose bengal
- SITS
- trans-ACDP
- Trypan blue
- Valinomycin
- Xanthurenic acid
|
|
|
Enzyme
(inhibitors) |
GAH |
|
|
AST |
- 2-Amino-3-butenoic acid
- AAOA
- AMB
- β-DL-Methylene-aspartate
- Hydrazinosuccinate
|
|
ALT |
- β-Chloro-L-alanine
- L-Cycloserine
- Propargylglycine
|
|
GDH |
- AAOA
- Bithionol
- Chloroquine
- EGCG
- GTP
- GW5074
- Hexachlorophene
- Hydroxylamine
- Palmitoyl-CoA
- Pyridoxal phosphate
|
|
GS |
- 2-Aminoadipic acid
- JFD01307SC
- Methionine sulfoximine
- Phosphinothricin (glufosinate)
|
|
GAD |
- 3-Mercaptopropionic acid
- AAOA
- L-Allylglycine
- Semicarbazide
|
|
|
Others |
- Precursors: GHB
- L-Glutamine
- Cofactors: α-Ketoglutaric acid
- Iron
- Sulfur
- Vitamin B2
- Vitamin B3
- Prodrugs: Aceglutamide (to L-glutamine)
- Others: Acamprosate
- Cysteine
- Cytidine
- Cytisine
- Glutathione
- Glutathione disulfide
- Minocycline
- N-Acetylcysteine
- Riluzole
- S-Nitrosoglutathione
- Tianeptine
|
|
See also: GABAergics • GHBergics • Glycinergics
|
|
Authority control |
- LCCN: sh85008689
- GND: 4211533-4
|
|